Patent applications and USPTO patent grants for Parks; Daniel J..The latest application filed is for "benzimidazole derivatives useful as cb-1 inverse agonists".
Patent | Date |
---|---|
Benzimidazole Derivatives Useful As Cb-1 Inverse Agonists App 20190031618 - Macielag; Mark J. ;   et al. | 2019-01-31 |
Benzimidazole derivatives useful as CB-1 inverse agonists Grant 10,118,900 - Macielag , et al. November 6, 2 | 2018-11-06 |
Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators Grant 9,718,820 - Player , et al. August 1, 2 | 2017-08-01 |
Benzimidazole Derivatives Useful As Cb-1 Inverse Agonists App 20170057929 - Macielag; Mark J. ;   et al. | 2017-03-02 |
Substituted Aza-bicyclic Imidazole Derivatives Useful As Trpm8 Receptor Modulators App 20160304518 - Player; Mark R. ;   et al. | 2016-10-20 |
Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators Grant 9,409,915 - Player , et al. August 9, 2 | 2016-08-09 |
PDE10a inhibitors for the treatment of type II diabetes Grant 9,249,163 - Player , et al. February 2, 2 | 2016-02-02 |
PDE 10a inhibitors for the treatment of type II diabetes Grant 9,193,736 - Player , et al. November 24, 2 | 2015-11-24 |
Substituted Aza-bicyclic Imidazole Derivatives Useful As Trpm8 Receptor Modulators App 20150158875 - Player; Mark R. ;   et al. | 2015-06-11 |
Substituted AZA-bicyclic imidazole derivatives useful as TRPM8 receptor modulators Grant 9,023,846 - Player , et al. May 5, 2 | 2015-05-05 |
PDE 10a Inhibitors for the Treatment of Type II Diabetes App 20140364414 - Player; Mark R. ;   et al. | 2014-12-11 |
PDE 10a Inhibitors for the Treatment of Type II Diabetes App 20140364413 - Player; Mark R. ;   et al. | 2014-12-11 |
Heterocyclic benzimidazoles as TRPM8 modulators Grant 8,232,409 - Player , et al. July 31, 2 | 2012-07-31 |
Heterocyclic Benzimidazoles As Trpm8 Modulators App 20100093788 - Player; Mark R. ;   et al. | 2010-04-15 |
Benzimidazole TRPV1 inhibitors Grant 7,612,211 - Cheung , et al. November 3, 2 | 2009-11-03 |
Factor Xa compounds Grant 7,446,210 - Lu , et al. November 4, 2 | 2008-11-04 |
Benzimidazole Trpv1 Inhibitors App 20080146637 - Cheung; Wing S. ;   et al. | 2008-06-19 |
Substituted 1,4-diazepines and uses thereof App 20060235007 - Lu; Tianbao ;   et al. | 2006-10-19 |
Substituted 1,4-diazepines and uses thereof Grant 7,115,598 - Lu , et al. October 3, 2 | 2006-10-03 |
Factor Xa compounds App 20060199809 - Lu; Tianbao ;   et al. | 2006-09-07 |
Substituted 1,4-benzodiazepines and uses thereof App 20060148792 - Lu; Tianbao ;   et al. | 2006-07-06 |
Substituted 1,4-benzodiazepines and uses thereof Grant 7,067,512 - Lu , et al. June 27, 2 | 2006-06-27 |
Substituted 1,4-diazepines and uses thereof App 20040220179 - Lu, Tianbao ;   et al. | 2004-11-04 |
Substituted 1,4-benzodiazepines and uses thereof App 20030109518 - Lu, Tianbao ;   et al. | 2003-06-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.